MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
US$106,800K Non Us$13,400K Revenue From ContractWith Customer...$41,900K Revenue From ContractWith Customer...$38,300K Net loss-$34,100K (-34000.00%↓ Y/Y)Cancer Care Continuum$120,200K Prenatal Health$41,900K Mental Health$38,300K Loss before incometax-$34,100K (-15.99%↓ Y/Y)Revenue$200,400K (2.30%↑ Y/Y)Operating loss-$30,700K (-5.86%↓ Y/Y)Total other expense,net-$3,400K (-750.00%↓ Y/Y)Gross profit$137,600K (2.53%↑ Y/Y)Interest income$700K (133.33%↑ Y/Y)Cost of revenue$62,800K (1.78%↑ Y/Y)Total operatingexpenses$168,300K (3.13%↑ Y/Y)Interest expense$4,100K (412.50%↑ Y/Y)Sales and marketingexpense$73,600K (6.36%↑ Y/Y)General andadministrative expense$62,200K (-6.47%↓ Y/Y)Research and developmentexpense$27,100K (-1.45%↓ Y/Y)Goodwill and long-livedasset impairment...$5,400K
Income Statement
source: myfinsight.com

MYRIAD GENETICS INC (MYGN)

MYRIAD GENETICS INC (MYGN)